• In early June 2026, Houlihan Lokey reported softer quarterly results amid valuation concerns but continued to strengthen its franchise by hiring senior bankers such as Dave Buscaglia in Business Services and Bodo Krug von Nidda in Capital Solutions to expand coverage in specialty consulting, risk services, and GP-led real estate secondaries.
• These hires deepen Houlihan Lokey’s expertise in capital solutions and business services at a time when investors are questioning how its growth plans, cost base, and high earnings multiples fit with its longer-term advisory-focused investment narrative.
• We’ll now consider how Houlihan Lokey’s softer quarter and senior hires in capital solutions may influence the existing investment narrative outlined above.

AI is about to change healthcare. These 39 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

Houlihan Lokey Investment Narrative Recap

To own Houlihan Lokey, you need to be comfortable with a people-intensive advisory model that depends on steady deal activity and disciplined costs. The recent stock pullback and softer quarter sharpen the focus on valuation risk and margins in the near term, but the new senior hires do not materially change the most important short term catalyst, which remains how quickly advisory volumes and fee pools recover relative to the firm’s elevated cost base.

Among the recent announcements, the arrival of Bodo Krug von Nidda into the Capital Solutions Group stands out. His GP led real estate secondaries expertise fits directly into Houlihan Lokey’s push to deepen higher value advisory in alternatives, which is central to the longer term narrative, even as investors currently focus on questions around cost discipline, earnings sensitivity to M&A volumes, and a rich earnings multiple.

Yet investors should also be aware that if high compensation costs persist while deal activity disappoints, the pressure on margins and valuation could...

Houlihan Lokey's narrative projects $3.6 billion revenue and $641.9 million earnings by 2029. This requires 10.8% yearly revenue growth and about a $194 million earnings increase from $447.8 million today.

Uncover how Houlihan Lokey's forecasts yield a $174.50 fair value, a 25% upside to its current price.

Exploring Other Perspectives

Some of the most optimistic analysts saw Houlihan Lokey reaching about US$4.0 billion of revenue and US$591.5 million of earnings, but this upbeat view of alternative asset advisory and GP led secondaries could look very different once the recent stock drop and senior hire news are fully reflected in updated forecasts, so it is worth comparing these bullish assumptions with more cautious scenarios before you decide how you feel about the stock.

Explore 2 other fair value estimates on Houlihan Lokey - why the stock might be worth just $174.50!

The Verdict Is Yours

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Houlihan Lokey research is our analysis highlighting 5 key rewards that could impact your investment decision.
• Our free Houlihan Lokey research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Houlihan Lokey's overall financial health at a glance.

Want Some Alternatives?

Don't miss your shot at the next 10-bagger. Our latest stock picks just dropped:

• The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 13 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.
• Rare earth metals are the new gold rush. Find out which 27 stocks are leading the charge.
• Invest in the nuclear renaissance through our list of 88 elite nuclear energy infrastructure plays powering the global AI revolution.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.